The PSA has welcomed the announcement by the AMA that it has presented the Government with a proposal to make non-dispensing pharmacists a key part of the general practice healthcare team.
National President of the PSA, Grant Kardachi, says both organisations and their members recognise the benefits that will flow from having pharmacists working closely with their medical colleagues in GP settings.
“As the AMA has said, this collaboration will create greater efficiencies for general practices, better care for patients, new career opportunities for pharmacists, and significant Budget savings across the whole health system,” Kardachi says.
“The proposal will see pharmacists in general practice settings involved in areas including medication management, patient education on their medications and supporting GP prescribing with advice on medication interactions and new medications.
“The AMA evidence shows the plan can reduce fragmentation of patient care, improve prescribing and use of medicines, reduce hospital admissions from adverse drug events and deliver better health outcomes for patients.”
Kardachi says research by Deloitte Access Economics shows that for every $1 invested in the program, $1.56 would be generated in savings to the health system.
“This team care approach is particularly important at time when the ageing population and increasing chronic disease are putting added pressures on the healthcare system,” Kardachi says.
“A PSA forum will be held in Sydney on Monday 24 August to discuss this area of practice.
“Those attending will hear from Australian experts in this area, including our own Dr Chris Freeman, GPs, and international expert Ravi Sharma from the UK.
“This is a genuinely collaborative model of care and represents an exciting step for the medical profession, for pharmacists and, most importantly, for patients.”